A phase 3, double-blind, randomized study of nivolumab and ipilimumab), nivolumab monotherapy, or placebo plus transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma Meeting Abstract
| Authors: | Sangro, B.; Harding, J.; Johnson, M.; Palmer, D.; Edeline, J.; Abou-Alfa, G.; Cheng, A.; Decaens, T.; El-Khoueiry, A.; Finn, R.; Galle, P.; Park, J.; Yau, T.; Begic, D.; Shen, Y.; Neely, J.; Sama, A.; Kudo, M. |
| Abstract Title: | A phase 3, double-blind, randomized study of nivolumab and ipilimumab), nivolumab monotherapy, or placebo plus transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma |
| Meeting Title: | 46th Annual Meeting of the Society of Interventional Radiology (SIR 2021) |
| Journal Title: | Journal of Vascular and Interventional Radiology |
| Volume: | 32 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2021 Mar 20-26 |
| Meeting Location: | Virtual Conference |
| ISSN: | 1051-0443 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2021-05-01 |
| Start Page: | S52 |
| End Page: | S53 |
| Language: | English |
| ACCESSION: | 149943242 |
| DOI: | 10.1016/j.jvir.2021.03.123 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 117 -- Accession Number: 149943242 -- Entry Date: In Process -- Revision Date: 20210426 -- Publication Type: Article -- Supplement Title: 2021 Supplement -- Journal Subset: Biomedical; Peer Reviewed; USA -- NLM UID: 9203369. -- Source: Cinahl |
Altmetric
Citation Impact
Related MSK Work